SynthesisBMC nephrology2020
The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis.
Synthesis in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Dialysis-Associated Acquired Cystic Kidney Disease as a Cause of Progressive Renal Hemorrhage in a Patient Receiving Hemodialysis: A Case Report.The American journal of case reports · 2026Article
- Strategic DAPT Interruption for Enlarging LV Pseudoaneurysm After Myocardial Infarction in a Dialysis Patient.JACC. Case reports · 2026Article
- Successful Treatment With Rituximab for Severe Immune Thrombocytopenic Purpura During Hemodialysis.Cureus · 2026Article
- Multinational Real-World Practice Patterns in the Use of Antithrombotic Therapy Among Patients on Hemodialysis and Peritoneal Dialysis.Kidney medicine · 2026Article
- Spontaneous spinal epidural hematoma - an uncommon cause of acute neurologic deficit in the emergency department: a case report.International journal of emergency medicine · 2025Article
- A Rare Case Report of Wunderlich Syndrome in a Chronic Hemodialysis Patient.Reports (MDPI) · 2025Article
- Wünderlich's syndrome in a haemodialysis patient.BMJ case reports · 2023Article
- Association between anticoagulation strategy and quality of life in chronic hemodialysis patients.Scientific reports · 2023Observational
- Comparison of revascularization with conservative medical treatment in maintenance dialysis patient with coronary artery disease: a systemic review and meta-analysis.Frontiers in cardiovascular medicine · 2023Review
- Rare case of intracerebral hemorrhage in anaphylactic shock following administration of intramuscular adrenaline: A case report.Clinical case reports · 2022Article
- Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients.Clinical kidney journal · 2022Article
- A Case of Bilateral Hemorrhagic Pleural Effusion Due to Dual Antiplatelet Therapy in a Dialysis Patient.Cureus · 2022Article
- The association between platelet indices and cardiovascular events in chronic kidney disease patients without dialysis.International urology and nephrology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundThe safety of antiplatelet therapy in haemodialysis (HD) patients remains controversial. we conducted the first meta-analysis to evaluate the bleeding risk with antiplatelet agents in these populations.
methodsThe relevant literature was searched using the following electronic databases without any language restrictions: the Cochrane Library, EMBASE, Global Health, MEDLINE, PubMed, and the Chinese Biomedical Database.
resultsSeven randomized controlled trials (RCTs) and 2 prospective cohort studies, consisting of 1131 patients, were identified for detailed evaluation. The meta-analysis suggested that the use of double antiplatelet agents increased the risk of bleeding in HD patients [odds ratio (OR) = 2.78; 95% confidence interval (CI) 1.63 to 4.76; I
conclusionThe results suggested that the use of double antiplatelet agents increased the risk of bleeding in HD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.